Earnings Release • May 11, 2020
Earnings Release
Open in ViewerOpens in native device viewer
May 11th, 2020

Today's presenters

Dr. Joachim Kuhn (CEO) Stefan Döhmen (CFO)



Good growth performance Revenue +15% to 17.6 Mio. EUR (Q1 2019: 15.2)
Systems revenue up 92% YOY to 4.8 Mio. EUR
(Q1 2019: 2.5 Mio. EUR)
EBITDA +27% to 2.8 Mio. EUR (Q1 2019: 2.2)
Healthcare & Logistics with >70% Revenue share
(Q1 2019: 59%)
5


In EUR Mio.

Q1 2020: 17.6 Mio. EUR






| in EUR Mio. | Q1 20 | Q1 19 |
|---|---|---|
| Operating cash flow before changes in Working Capital |
2.0 | 0.5 |
| Operating cash flow | 1.5 | -0.9 |
| Investing cash flow |
-2.1 | -1.3 |
| thereof payments for investments in property, plant and equipment |
-1.8 | -1.4 |
| Financing cash flow |
2.3 | -2.0 |
| Net change in cash | 1.6 | -4.3 |
| Free Cash flow | -0.6 | -2.2 |



FY 2019 FY 2020 Outlook incl. possible CoVid-19 effects FY 2020 Outlook excl. CoVid-19 effects 64,7 Mio EUR +28% Moderate to medium growth Medium to strong revenue growth 13% on Total income, 15% on Revenue Stable margin Margin increase Revenue EBITDA


Currently >50% of all intl. transported testkits use VQT solutions
Temperature – Time – Testified Precision
Alfred-Nobel-Straße 33 97080 Würzburg Tel.: +49 931 35942-1616 Fax: +49 931 35942-0 [email protected]
Symbol: VQT Bloomberg: VQT:GY Reuters: VQTG:DE ISIN: DE0006636681 WKN: 663668
15
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.